title: Lipoproteins and free plasma catecholamines in spinal cord injured men with different injury levels.
abstract: Persons with spinal cord injury (SCI) are especially prone to atherogenesis. This is partly explained by an unfavourable lipoprotein profile in these individuals. The impairment of the sympathetic nervous system, and the fact that SCI subjects are subject to extreme physical inactivity, may have an influence on their lipid profile and lipoprotein(a) concentration. We made a detailed investigation of the lipid profile as well as serum levels of adrenaline and noradrenaline in 80 men with SCI ranging from tetraplegia to low paraplegia and in 16 control subjects. The lipid profile of tetraplegics was characterized by elevated very low-density lipoprotein cholesterol and triglyceride levels and reduced high-density lipoprotein levels. In contrast, paraplegics had significantly higher low-density lipoprotein and total cholesterol levels. Tetraplegics had lower and the low-lesion paraplegics had higher adrenaline and noradrenaline levels than the high-lesion paraplegics and the control subjects. High-lesion SCI subjects also showed an extreme reduction in VO2max. The lipoprotein profile was dependent on the injury level and serum catecholamine concentrations. The lower the noradrenaline values, the lower the high-density lipoprotein cholesterol. The low-density lipoprotein also correlated to catecholamines and particularly adrenaline values. Despite the correlation between lipoprotein(a) and adrenaline, no significant differences in lipoprotein(a) were found within SCI individuals as well as between SCI individuals and control subjects, indicating the predominantly genetic determination of lipoprotein(a) and thus the cardiovascular risk. Different serum catecholamine levels due to impairment of sympathetic nervous system and VO2max levels were observed in SCI subjects. This was associated with a higher lipid risk profile for cardiovascular diseases; however, the risk profile is dependent on the lesion level.
authors.affiliation: University of Freiburg, Centre for Internal Medicine, Department of Prevention, Rehabilitation and Sports Medicine, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Schmid
authors.forename: M
authors.initials: M
authors.lastname: Halle
authors.forename: C
authors.initials: C
authors.lastname: Stützle
authors.forename: D
authors.initials: D
authors.lastname: König
authors.forename: M W
authors.initials: MW
authors.lastname: Baumstark
authors.forename: M J
authors.initials: MJ
authors.lastname: Storch
authors.forename: A
authors.initials: A
authors.lastname: Schmidt-Trucksäss
authors.forename: M
authors.initials: M
authors.lastname: Lehmann
authors.forename: A
authors.initials: A
authors.lastname: Berg
authors.forename: J
authors.initials: J
authors.lastname: Keul
mesh_terms: D000328:Adult; D001161:Arteriosclerosis / Q000209:etiology; D004837:Epinephrine / Q000097:blood*; D006801:Humans; D017270:Lipoprotein(a) / Q000097:blood*; D008297:Male; D009638:Norepinephrine / Q000097:blood*; D011782:Quadriplegia / Q000150:complications; D012307:Risk Factors; D012720:Severity of Illness Index; D013119:Spinal Cord Injuries / Q000097:blood* / Q000150:complications
chemical_list: D017270:Lipoprotein(a); D009638:Norepinephrine; D004837:Epinephrine